BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35988109)

  • 1. Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine.
    Monzani ML; Piccinini F; Boselli G; Corleto R; Margiotta G; Peeters RP; Simoni M; Brigante G
    J Endocrinol Invest; 2023 Feb; 46(2):319-326. PubMed ID: 35988109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
    Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
    J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.
    Lombardi CP; Bocale R; Barini A; Barini A; D'Amore A; Boscherini M; Bellantone R
    Endocrine; 2017 Jan; 55(1):51-59. PubMed ID: 27388589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life, Anxiety and Depression in Patients with Differentiated Thyroid Cancer under Short Term Hypothyroidism Induced by Levothyroxine Withdrawal.
    Badihian S; Jalalpour P; Mirdamadi M; Moslehi M
    Klin Onkol; 2016; 29(6):439-444. PubMed ID: 27951721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer.
    Massolt ET; van der Windt M; Korevaar TI; Kam BL; Burger JW; Franssen GJ; Lehmphul I; Köhrle J; Visser WE; Peeters RP
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):781-788. PubMed ID: 27175823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Kudo T; Nishihara E; Kihara M; Ito Y; Miya A; Fukata S; Nishikawa M; Nakamura H
    Endocr J; 2019 Nov; 66(11):953-960. PubMed ID: 31270299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients.
    Yavuz DG; Yazan CD; Hekimsoy Z; Aydin K; Gokkaya N; Ersoy C; Akalın A; Topaloglu O; Aydogan BI; Dilekci ENA; Alphan Uc Z; Cansu GB; Ozsari L; Iyidir OT; Olgun ME; Keskin L; Mert M; Can B; Gungor K; Galip T; Cantürk Z; Elbuken G; Pekkolay Z; Kutbay NO; Yorulmaz G; Kalkan AT; Unsal YA; Yay A; Karagun B; Bozkur E
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):833-840. PubMed ID: 35639050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
    Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
    Altuntaş SÇ; Hocaoğlu Ç
    Horm Metab Res; 2021 Oct; 53(10):683-691. PubMed ID: 34607367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer-phase I/II study.
    Lin YS; Yang H; Li XY; Wu LQ; Xu JG; Yang AM; Gao ZR; Ding Y; Zhang YQ; Chen K; Mu ZZ; Jia JM; Niu N; Sun D; Zhang X; Zhang SQ; Geng QQ; Zhang YJ; Chen FN; He BX
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4171-4181. PubMed ID: 35781600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
    Vigário Pdos S; Chachamovitz DS; Teixeira Pde F; Rocque Mde L; Santos ML; Vaisman M
    Arq Bras Endocrinol Metabol; 2014 Apr; 58(3):274-81. PubMed ID: 24863090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
    Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
    Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of thyroid hormone supplementation after thyroid lobectomy.
    Lee DY; Seok J; Jeong WJ; Ahn SH
    J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Human Thyrotropin Worsens Renal Cortical Perfusion and Renal Function in Patients After Total Thyroidectomy Due to Differentiated Thyroid Cancer.
    Saracyn M; Lubas A; Bober B; Kowalski Ł; Kapusta W; Niemczyk S; Wartofsky L; Kamiński G
    Thyroid; 2020 May; 30(5):653-660. PubMed ID: 31964314
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative cross-sectional study on sleep quality in patients with a history of differentiated thyroid carcinoma and its correlation with quality of life.
    Teliti M; Monti E; Comina M; Conte L; Vera L; Gay S; Saccomani G; Ferone D; Giusti M
    Endocrine; 2021 Aug; 73(2):347-357. PubMed ID: 33537955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
    Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
    Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
    [No Abstract]   [Full Text] [Related]  

  • 18. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
    Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
    Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life following lobectomy versus total thyroidectomy is significantly related to hypothyroidism.
    Yaniv D; Vainer I; Amir I; Robenshtok E; Hirsch D; Watt T; Hilly O; Shkedy Y; Shpitzer T; Bachar G; Feinmesser R; Mizrachi A
    J Surg Oncol; 2022 Sep; 126(4):640-648. PubMed ID: 35689620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Related Quality of Life in Elderly with Subclinical Hypothyroidism and Improvement on Levothyroxine is Distinct from that in Young Patients (TSAGE).
    Recker S; Voigtländer R; Viehmann A; Dunschen K; Kerp H; Frank-Raue K; Leidig-Bruckner G; Graf D; Lederbogen S; Dietrich JW; Görges R; Brabant G; Völker U; Watt T; Zwanziger D; Moeller LC; Führer D
    Horm Metab Res; 2019 Sep; 51(9):568-574. PubMed ID: 31505703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.